Clinical Trials List
Protocol NumberPCI-32765CAN3001
2016-11-01 - 2024-12-31
Phase III
Recruiting1
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2023/03/10
Investigators and Locations
Co-Principal Investigator
- 賴冠銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
700 participants
